≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Calcific tendinitis

DOID EFO Endpoint Browser PheWeb

M13_CALCTENDINITIS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M65.2
  • Cause of death: ICD-10 — M65.2

2 out of 7 registries used, show all original rules.

342

4. Check minimum number of events

None

342

5. Include endpoints

None

342

6. Filter based on genotype QC (FinnGen only)

342

Control definitions (FinnGen only)

Control exclude
M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M65
Name in latin
Tendinitis calcificans

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2142 1286 852
Only index persons 2086 1262 824
Unadjusted period prevalence (%)
Whole population 0.03 0.04 0.02
Only index persons 0.04 0.05 0.03
Median age at first event (years)
Whole population 50.24 50.75 49.52
Only index persons 50.18 50.65 49.47

-FinnGen-

Key figures

All Female Male
Number of individuals 342 210 132
Unadjusted period prevalence (%) 0.07 0.07 0.06
Median age at first event (years) 52.66 50.49 56.11

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
307
Matched controls
3071
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M65.2
ICD-10 Finland
Calcific tendinitis
+∞
323.0
306
*
M75.1
ICD-10 Finland
Rotator cuff syndrome
10.3
60.2
137
222
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
42.8
50.2
62
18
M75.3
ICD-10 Finland
Calcific tendinitis of shoulder
283.2
48.5
48
*
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
33.4
40.7
53
19
NBG10
NOMESCO Finland
Acromioplastia
59.2
27.8
32
6
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
271.1
25.1
25
*
M01AH05
ATC
etoricoxib; oral
3.6
24.1
223
1293
M79.6
ICD-10 Finland
Pain in limb
3.9
23.9
126
466
N02AX02
ATC
tramadol; systemic, rectal
3.4
22.4
156
710
N03AX12
ATC
gabapentin; oral
5.4
21.1
69
157
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
14.0
20.4
35
28
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
25.7
19.0
26
11
N03AX16
ATC
pregabalin; oral
3.7
18.0
93
323
M01AB05
ATC
diclofenac; systemic, rectal
3.1
17.1
233
1558
M65.3
ICD-10 Finland
Trigger finger
16.3
17.0
27
18
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.8
16.7
162
870
M25.5
ICD-10 Finland
Pain in joint
3.0
14.9
106
459
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
22.4
14.9
21
10
M03BX02
ATC
tizanidine; oral
2.7
14.5
220
1481
M79.0
ICD-10 Finland
Rheumatism, unspecified
31.7
14.0
18
6
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
3.9
13.9
62
189
M54.4
ICD-10 Finland
Lumbago with sciatica
3.6
13.7
68
226
NHL16
NOMESCO Finland
Tenolysis or tenosynovectomy of achilles tendon
146.2
13.6
14
*
M48.0
ICD-10 Finland
Spinal stenosis
4.8
13.5
46
108
M19.0
ICD-10 Finland
Primary arthrosis of other joints
4.9
13.0
44
102
M01AH01
ATC
celecoxib; oral (coxibs)
3.2
12.5
74
279
NDM20
NOMESCO Finland
Excision of synovial ganglion of wrist or hand
135.3
12.5
13
*
M02AA07
ATC
piroxicam; topical
2.5
12.2
128
682
NBF25
NOMESCO Finland
Operation for humeroscapular osteochondritis, arthroscopic
22.4
12.1
17
8
M54.5
ICD-10 Finland
Low back pain
2.6
11.4
105
515
M01AC06
ATC
meloxicam; systemic, rectal
2.4
11.4
130
718
H02AB06
ATC
prednisolone; systemic
2.3
11.4
156
942
N02BE01
ATC
paracetamol; systemic, rectal
3.0
10.9
270
2177
M03BC01
ATC
orphenadrine (citrate); systemic
2.7
10.8
87
397
G56.0
ICD-10 Finland
Carpal tunnel syndrome
3.4
10.7
55
186
M01AX17
ATC
nimesulide; oral
2.7
10.7
87
398
M67.4
ICD-10 Finland
Ganglion
8.2
10.6
23
30
A02BC03
ATC
lansoprazole; oral
2.4
10.5
106
545
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
7.3
10.3
24
35
M75.2
ICD-10 Finland
Bicipital tendinitis
14.0
9.8
16
12
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
4.9
9.6
31
69
Z01.8
ICD-10 Finland
Other specified special examinations
2.6
9.5
78
357
M01AB55
ATC
diclofenac, combinations; oral
4.6
9.4
32
75
M01AE02
ATC
naproxen; oral, rectal
2.1
9.4
181
1235
N02AJ06
ATC
codeine and paracetamol; systemic
2.2
9.3
116
655
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.0
9.2
37
102
UJF32
NOMESCO Finland
Coloscopy
2.4
9.1
86
421
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
9.0
128
765
N06AA09
ATC
amitriptyline; systemic
3.7
8.8
38
112
9242
FHL
Other reconstruction or plastic surgery of shoulder joint (including ac joint)
51.5
8.7
10
*
M01AE03
ATC
ketoprofen; systemic, rectal
2.1
8.7
126
753
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.9
8.7
54
209
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.3
8.5
94
496
M79.1
ICD-10 Finland
Myalgia
3.6
8.4
38
117
ACC51
NOMESCO Finland
Release of median nerve
4.1
8.3
32
85
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
6.8
8.3
20
31
NDM10
NOMESCO Finland
Palmar fasciotomy of hand
34.3
8.1
10
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.2
8.1
92
492
M70.6
ICD-10 Finland
Trochanteric bursitis
3.2
8.1
42
144
L08
ICPC
Shoulder symptom/complaint
2.6
8.0
64
284
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
8.0
91
485
A02BC01
ATC
omeprazole; systemic
2.2
7.9
91
488
J01DB01
ATC
cefalexin; oral
2.3
7.8
250
2026
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.5
7.8
36
113
SFA10
NOMESCO Finland
Fillning on one surface of tooth
2.0
7.8
165
1137
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
4.6
7.7
26
61
SPAT1263
SPAT
Sampling
2.0
7.6
126
785
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
4.3
7.6
27
67
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
7.4
7.6
17
24
NDA30
NOMESCO Finland
Exploration of joint of wrist or hand, arthroscopic
82.0
7.4
8
*
R42
ICD-10 Finland
Dizziness and giddiness
2.4
7.4
65
304
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.9
7.3
180
1297
7261A
ICD-9 Finland
Peripheral enthesopathies and allied syndromes, Rotator cuff syndrome of shoulder and allied disorders[TENDINITIS CALCIFICANS HUMEROSCAPULARIS]
+∞
7.3
7
*
L03
ICPC
Low back symptom/complaint
2.3
7.3
72
359
SPAT1153
SPAT
Removal of sutures
2.1
7.3
103
600
M17.1
ICD-10 Finland
Other primary gonarthrosis
2.4
7.2
62
288
R01AD09
ATC
mometasone; nasal
1.9
7.2
144
962
M75.5
ICD-10 Finland
Bursitis of shoulder
12.4
7.1
12
10
M53.1
ICD-10 Finland
Cervicobrachial syndrome
3.0
7.0
40
145
SPAT1260
SPAT
Consultation of another employee
2.4
7.0
59
272
N06AX21
ATC
duloxetine; oral
3.2
7.0
36
123
J01CA04
ATC
amoxicillin; systemic
2.1
6.9
244
1992
S18
ICPC
Laceration/cut
2.0
6.9
125
799
M77.1
ICD-10 Finland
Lateral epicondylitis
4.1
6.8
25
65
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.1
6.8
36
126
K02.1
ICD-10 Finland
Caries of dentine
1.9
6.7
167
1195
NBT60
NOMESCO Finland
Forcible manipulation of humeroscapular joint
23.1
6.7
9
*
SAA02
NOMESCO Finland
Basic examination of mouth
1.9
6.7
191
1430
J01DA01
ATC
[U] cefalexin; systemic
1.9
6.7
194
1462
J01AA02
ATC
doxycycline; systemic
2.1
6.6
244
2002
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
12.6
6.6
11
9
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
6.6
100
595
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
6.6
82
450
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.2
6.6
69
353
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.9
6.5
149
1031
M76.6
ICD-10 Finland
Achilles tendinitis
6.2
6.4
16
27
J45.9
ICD-10 Finland
Asthma, unspecified
2.4
6.4
57
269
A02BC02
ATC
pantoprazole; systemic
1.9
6.4
195
1484
A02BC05
ATC
esomeprazole; systemic
1.9
6.3
124
811
R03AC02
ATC
salbutamol; inhalant
1.8
6.3
157
1113
M72.0
ICD-10 Finland
Palmar fascial fibromatosis [Dupuytren]
18.5
6.3
9
5
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.8
6.3
168
1218
R03DC03
ATC
montelukast; oral
2.4
6.3
54
250
NBL50
NOMESCO Finland
Tenolysis or tenosynovectomy of shoulder or upper arm
+∞
6.3
6
*
NB1ZT
NOMESCO Finland
Crushing of soft tissue calcifications in shoulder wiht ultrasound quidance
+∞
6.3
6
*
H02BX01
ATC
methylprednisolone, combinations; systemic
4.4
6.3
21
50
WX204
NOMESCO Finland
Axillary plexus blockaced
6.5
6.2
15
24
WX400
NOMESCO Finland
Inhalation anesthesy
4.9
6.2
19
41
P01AB01
ATC
metronidazole; oral, rectal
1.9
6.2
128
851
M02AA10
ATC
ketoprofen; topical
2.4
6.1
54
254
M65.4
ICD-10 Finland
Radial styloid tenosynovitis [de Quervain]
12.9
6.1
10
8
M54.6
ICD-10 Finland
Pain in thoracic spine
3.5
6.1
27
83

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
82
402
2.37
9.67
1.3
1.2
u/ml
5.1
20.1
1.67
42
159
(3026493) Urate [Moles/volume] in Serum or Plasma
118
675
2.14
9.57
2.8
2.6
umol/l
335.7
10822.0
4.41
103
578
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
85
434
2.28
9.08
1.3
1.2
iu/ml
25.1
39.6
0.77
25
154
(3013707) Erythrocyte sedimentation rate by Westergren method
255
1998
2.09
8.05
4.9
3.6
mm/h
11.9
11.8
0.06
245
1846
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
269
2156
2.16
7.90
4.2
3.8
pmol/l
14.8
14.7
0.31
247
1962
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
266
2169
2.02
6.79
6.4
7.8
u/l
72.1
79.9
3.60
254
2044
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
149
1018
1.82
6.70
4.0
3.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
315
2785
2.66
5.95
14.2
12.8
mg/l
21.2
24.1
0.77
255
2155
(3035350) Ketones [Presence] in Urine by Test strip
174
1280
1.73
5.83
3.9
3.2
estimate
0.0
0.0
0.00
39
224
(3009261) Glucose [Presence] in Urine by Test strip
175
1314
1.68
5.25
3.9
3.2
estimate
0.0
0.0
0.00
39
214
(3021601) Nitrite [Presence] in Urine by Test strip
173
1296
1.68
5.23
4.8
4.5
estimate
0.0
0.0
0.00
39
225
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
298
2607
2.11
5.20
5.2
4.4
mu/l
2.0
1.9
0.51
276
2379
(3029937) Albumin [Presence] in Urine by Test strip
102
663
1.77
5.17
4.7
3.4
estimate
0.0
0.0
0.50
38
217
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
13
32
4.18
4.94
2.1
2.4
mg/l
8.6
17.6
—
5
8
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
306
2717
2.20
4.92
6.7
5.3
mmol/mol
40.9
39.6
1.46
286
2533
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
107
715
1.72
4.89
3.1
3.3
ng/l
865.6
1119.7
0.43
94
611
(4010399)
41
199
2.20
4.84
1.6
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
322
2928
2.71
4.78
4.9
4.4
mmol/l
4.7
4.8
1.06
298
2742
(40761511) CBC panel - Blood by Automated count
327
3003
3.03
4.63
14.7
11.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
224
1833
1.64
4.49
4.4
3.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
53
292
1.96
4.48
1.9
2.5
ug/g
250.0
138.8
0.38
39
244
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
320
2916
2.51
4.46
4.8
4.3
mmol/l
1.4
1.5
2.32
298
2708
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
174
1345
1.60
4.37
6.5
7.1
mmol/l
1.2
1.2
0.17
140
1146
(3019150) Specific gravity of Urine by Refractometry
84
545
1.72
4.20
4.3
3.5
kg/l
1.0
1.0
0.08
12
82
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
324
2983
2.64
4.16
5.3
4.8
mmol/l
2.8
2.8
1.07
299
2770
(3013826) Glucose [Moles/volume] in Serum or Plasma
192
1535
1.57
4.06
4.6
4.9
mmol/l
6.8
6.7
0.15
181
1443
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
203
1649
1.57
3.97
2.5
2.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
117
838
1.60
3.96
2.6
2.4
u/l
53.2
59.9
1.80
107
777
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
311
2828
2.10
3.90
4.4
3.9
mmol/l
1.4
1.3
1.98
289
2622
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
109
775
1.60
3.78
2.4
2.1
u/l
190.9
193.3
0.02
98
728
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
145
1101
1.55
3.77
2.4
2.2
nmol/l
79.9
77.4
0.48
130
1005
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
53
314
1.81
3.59
6.2
6.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
312
2856
2.05
3.59
4.8
4.4
mmol/l
6.2
5.9
1.89
283
2633
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
119
2.28
3.55
1.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
36
188
2.02
3.54
3.5
3.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
172
1369
1.52
3.53
5.8
5.4
e9/l
2.0
2.0
0.28
155
1205
(3023103) Potassium [Moles/volume] in Serum or Plasma
322
2991
2.31
3.42
15.3
14.7
mmol/l
4.0
4.0
0.43
317
2917
(3019060) Gas panel - Arterial blood
32
163
2.06
3.37
4.2
7.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
329
3088
2.72
3.35
10.8
10.0
u/l
28.0
26.3
0.72
320
2979
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
153
1200
1.50
3.31
5.1
6.2
mmol/l
1.2
1.2
0.05
132
1094
(3025941) Bacteria identified in Stool by Culture
26
124
2.19
3.23
1.3
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
60
381
1.70
3.21
1.3
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
81
557
1.60
3.17
3.6
3.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
48
291
1.76
3.02
2.3
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
52
323
1.72
3.01
1.3
1.3
titre
1268.6
418.8
—
7
66
(3001604) Monocytes [#/volume] in Blood
166
1345
1.46
2.95
5.7
5.4
e9/l
0.6
0.6
1.12
149
1154
(3026361) Erythrocytes [#/volume] in Blood
335
3214
3.07
2.90
21.3
18.7
e12/l
4.5
4.5
0.24
328
3129
(3010813) Leukocytes [#/volume] in Blood
335
3214
3.07
2.90
21.3
18.8
e9/l
6.9
6.5
3.31
328
3129
(3007461) Platelets [#/volume] in Blood
335
3213
3.08
2.90
21.1
18.7
e9/l
258.8
252.8
1.09
330
3135
(40768797) Stomach Pathology biopsy report
57
368
1.66
2.86
1.2
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
170
1389
1.45
2.86
5.9
5.8
e9/l
0.2
0.2
1.99
153
1218
(3006315) Basophils [#/volume] in Blood
166
1352
1.44
2.83
5.7
5.4
e9/l
0.0
0.0
0.50
149
1162
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
14
53
2.71
2.83
1.1
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
6
8.43
2.76
1.0
1.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
127
990
1.45
2.71
4.6
3.3
ng/l
99.3
29.2
0.50
89
668
(3002179) Metamyelocytes/100 leukocytes in Blood
36
207
1.83
2.70
3.5
4.0
%
0.3
0.6
—
6
54
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
79
560
1.53
2.69
1.2
1.2
u/ml
1.5
2.0
0.16
29
147
(3024561) Albumin [Mass/volume] in Serum or Plasma
148
1193
1.42
2.61
4.2
4.8
g/l
36.0
35.8
0.25
138
1129
(3025159) Blasts/100 leukocytes in Blood
35
203
1.81
2.56
4.3
4.3
%
0.0
0.1
—
7
54
(3021440) Promyelocytes/100 leukocytes in Blood
36
212
1.78
2.51
4.1
4.3
%
0.0
0.1
—
8
64
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
78
564
1.50
2.41
1.9
1.7
mg/l
1.0
1.2
0.34
62
436
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
8
6.32
2.38
1.0
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
38
232
1.72
2.35
4.0
4.1
%
0.5
1.0
—
8
75
(3032080) INR in Blood by Coagulation assay
135
1088
1.40
2.32
5.9
8.0
inr
1.2
1.2
0.36
36
325
(3008898) HLA-B27 [Presence]
16
72
2.28
2.31
1.1
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
173
1455
1.38
2.30
4.8
7.2
umol/l
10.3
11.4
0.91
163
1394
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
12
47
2.61
2.29
1.2
1.2
mg/l
495.1
431.1
0.29
12
42
(3018010) Neutrophils/100 leukocytes in Blood
155
1286
1.38
2.21
5.7
5.3
%
56.7
56.9
0.06
141
1199
(42870588) Differential panel, method unspecified - Blood
112
882
1.40
2.18
4.9
5.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
45
294
1.61
2.17
3.8
9.6
mmol/l
2.1
1.0
1.22
34
235
(3002030) Lymphocytes/100 leukocytes in Blood
156
1301
1.37
2.14
5.9
5.6
%
29.4
28.1
0.80
144
1206
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
217
1907
1.38
2.13
3.1
3.0
u/l
53.5
53.8
0.02
199
1791
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
10
5.06
2.07
1.0
1.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
80
599
1.44
2.06
4.9
4.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
74
549
1.44
2.00
1.8
1.7
pmol/l
109836499.6
23739925.8
0.35
61
476
(44813793)
7
21
3.38
1.97
1.0
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
16
3.80
1.94
1.0
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
145
1214
1.34
1.87
4.3
3.9
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
151
1273
1.33
1.86
6.4
5.7
%
8.4
8.8
0.69
141
1190
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
44
298
1.55
1.84
1.6
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
95
748
1.37
1.82
3.8
2.9
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
150
1267
1.33
1.81
5.8
5.4
%
3.0
2.8
0.49
139
1176
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
24
140
1.77
1.77
3.0
3.8
mmol/l
1.4
2.4
0.57
16
103
(3012516) Albumin [Mass/volume] in Urine
101
808
1.35
1.75
3.4
3.1
mg/l
55.9
293.9
1.00
76
515
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
41
277
1.55
1.74
1.5
1.9
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
30
2.71
1.73
3.1
3.3
e9/l
3.2
4.2
—
8
30
(3044889) 12 lead EKG panel
230
2076
1.33
1.68
4.2
3.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
49
347
1.48
1.68
3.1
2.4
%
23.1
23.1
0.00
41
302
(3013650) Neutrophils [#/volume] in Blood by Automated count
181
1587
1.30
1.61
7.5
9.7
e9/l
4.3
4.0
1.17
165
1388
(3035637) Corticotropin [Mass/volume] in Plasma
8
32
2.54
1.60
1.1
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
32
2.54
1.60
4.1
3.4
%
53.5
55.5
—
8
32
(4035726)
16
283
0.54
1.60
2.1
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
145
1236
1.30
1.59
10.8
8.8
e9/l
0.0
0.0
0.03
127
1011
(3020682) Albumin/Creatinine [Ratio] in Urine
106
866
1.32
1.58
3.9
3.7
mg/mmol
15.7
7.5
0.72
81
539
(3022096) Basophils/100 leukocytes in Blood
144
1230
1.29
1.54
5.6
5.4
%
0.8
0.7
1.20
134
1146
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40
278
1.50
1.51
1.6
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
22
132
1.71
1.50
2.5
2.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
60
453
1.39
1.47
2.0
1.7
nmol/l
1214.9
1181.9
0.11
48
344
(3009508) Creatinine [Moles/volume] in Urine
103
847
1.31
1.45
3.3
2.9
mmol/l
7.8
7.7
0.04
94
716
(3004616) Nuclear Ab [Presence] in Serum
7
29
2.44
1.40
1.6
1.3
—
—
—
0
0
(3020891) Body temperature
16
89
1.84
1.39
6.1
3.8
—
—
—
0
0
(3013512) EKG study
98
806
1.30
1.38
4.6
3.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
17
2.97
1.36
1.0
1.1
—
—
—
0
0
(4281824)
0
37
0.00
1.35
0.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
37
0.00
1.35
0.0
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
24
153
1.61
1.33
1.7
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
9
43
2.12
1.31
1.8
3.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
66
517
1.34
1.30
2.9
2.3
e6/l
8.0
7.4
0.09
61
445
(3026389) Candida sp identified in Specimen by Organism specific culture
8
34
2.38
1.30
1.1
1.1
—
—
—
0
0
(4024509)
5
18
2.80
1.29
1.0
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
18
2.80
1.29
1.0
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
108
909
1.27
1.26
2.9
3.9
mmol/l
2.3
2.4
0.49
95
819
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
291
2760
1.36
1.24
12.0
11.9
ml/min/173m2
81.2
80.5
0.27
230
2294
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
48
360
1.39
1.24
4.8
4.3
%
33.5
31.3
0.80
32
242
(3044290) Cell count panel - Cerebral spinal fluid
8
37
2.19
1.22
1.0
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
84
688
1.29
1.21
2.6
2.7
—
—
—
0
0
(3000492) Spirometry study
36
258
1.44
1.20
1.3
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
14
79
1.81
1.18
1.3
1.4
ug/g
375.6
324.3
—
8
44
(3037756) Immunofixation for Serum or Plasma
11
57
1.96
1.18
1.6
1.8
—
—
—
0
0
(4094501)
13
72
1.84
1.16
1.3
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
52
400
1.35
1.16
1.6
1.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
8
40
2.02
1.13
1.3
1.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
13
73
1.81
1.12
1.5
1.3
g/l
0.2
0.2
1.34
13
67
(3028271) Lactate [Moles/volume] in Capillary blood
7
31
2.28
1.11
1.9
1.9
mmol/l
1.4
1.7
—
7
31
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
81
1.76
1.10
1.5
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
21
2.40
1.09
2.0
4.4
—
—
—
0
0
(3019225) pH of Specimen
35
256
1.41
1.06
4.6
4.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
25
171
1.50
1.05
1.9
1.9
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
13
75
1.76
1.04
1.5
1.3
g/l
1.1
1.2
0.79
13
70
(3002256) Pathology report gross observation
29
397
0.71
1.01
1.4
1.2
—
—
—
0
0
(4146454)
5
23
2.19
0.98
3.8
2.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
74
613
1.26
0.98
2.6
2.0
mg/l
3.0
3.1
0.26
69
520
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
36
1.96
0.97
1.3
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
31
0.00
0.97
0.0
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
24
167
1.47
0.95
1.3
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
26
184
1.45
0.95
3.2
3.4
e9/l
4.3
4.0
0.42
17
146
(3023520) Reticulocytes [#/volume] in Blood
28
202
1.42
0.93
2.7
2.8
e9/l
68.0
68.9
0.05
21
153
(3037121) Protein [Mass/volume] in Urine
15
94
1.62
0.92
2.7
4.2
g/l
0.2
0.2
—
6
41
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
23
160
1.47
0.91
1.8
1.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
131
1163
1.20
0.90
2.8
2.5
ug/l
138.8
143.3
0.07
123
1077
(3022313) Gas panel - Capillary blood
17
112
1.54
0.86
3.1
3.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
43
338
1.31
0.86
2.2
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
45
1.80
0.85
1.4
1.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
31
1.95
0.85
3.0
3.6
nmol/l
4.2
3.7
—
6
31
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
111
0.53
0.84
1.3
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
21
146
1.47
0.84
3.8
14.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
46
1.76
0.83
2.1
2.8
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
99
863
1.21
0.82
4.3
4.8
ug/l
16.3
2.7
0.47
78
774
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
58
1.75
0.80
1.7
1.7
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
11
66
1.69
0.79
2.4
1.4
nmol/l
37.3
43.6
0.46
11
66
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
8
48
1.68
0.79
1.1
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
26
0.00
0.78
0.0
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
60
499
1.25
0.78
3.5
3.7
ng/l
314.6
409.6
0.15
47
390
(3018418) pH of Serum or Plasma
94
820
1.20
0.77
3.3
4.0
ph
7.4
7.4
0.39
25
149
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
28
0.00
0.76
0.0
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
28
0.00
0.76
0.0
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
28
0.00
0.76
0.0
1.9
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
67
1.66
0.76
1.5
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
67
1.66
0.76
1.2
1.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
44
355
1.27
0.74
2.5
2.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
118
1055
1.18
0.74
2.0
1.9
pmol/l
105.1
95.7
1.20
64
551
(3005570) Glucose [Moles/volume] in Urine
5
25
2.01
0.73
2.4
2.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
25
2.01
0.73
1.2
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
15
101
1.51
0.71
1.1
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
26
1.94
0.71
1.6
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
26
1.94
0.71
1.0
1.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
24
317
0.74
0.70
2.0
2.5
umol/l
19.7
8.5
0.38
17
276
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
28
214
1.34
0.69
3.1
2.5
ml/min/173m2
74.5
65.9
0.55
11
84
(3022145) Colonoscopy Study observation
38
304
1.28
0.69
1.2
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
25
189
1.35
0.66
1.2
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
252
2406
1.18
0.66
15.9
15.6
%
13.6
13.7
1.08
247
2352
(3044927) Protein electrophoresis panel - Urine
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
27
209
1.32
0.62
1.4
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
63
727
0.84
0.61
1.3
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
127
1158
1.15
0.61
1.8
2.1
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
12.6
—
798.3
—
0
21
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
15.7
—
1468.1
—
0
21
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
21
0.00
0.60
0.0
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
65
1.55
0.56
1.6
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
16
116
1.40
0.55
1.1
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
15
108
1.41
0.54
1.7
1.6
g/l
1.4
1.6
0.29
15
97
(3003327) Ova and parasites identified in Stool by Light microscopy
11
74
1.50
0.54
2.4
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
21
161
1.32
0.53
2.8
3.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
32
261
1.25
0.52
2.0
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
65
1.39
0.51
2.1
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
14
101
1.40
0.50
1.8
1.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
105
957
1.14
0.50
3.0
2.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
76
1.46
0.48
2.1
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
78
698
1.15
0.48
4.5
4.2
%
25.9
21.1
1.49
34
333
(40768793) Breast Pathology biopsy report
5
81
0.61
0.46
1.4
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
83
749
1.14
0.46
2.7
2.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
34
284
1.22
0.46
2.0
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
12
86
1.41
0.45
2.6
2.8
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
17
131
1.31
0.43
1.1
1.1
—
132.0
—
0
5
(3028626) Oxygen [Partial pressure] in Capillary blood
8
57
1.41
0.42
2.1
2.9
kpa
8.3
7.9
—
8
52
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.9
—
904.9
—
0
15
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
19
150
1.28
0.41
4.1
9.9
%
94.6
93.3
0.92
19
150
(3026782) Osmolality of Urine
56
496
1.15
0.40
2.9
2.5
mosm/kgh2o
564.3
570.9
0.07
49
421
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
18
0.00
0.40
0.0
2.8
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
57
509
1.14
0.37
1.5
1.4
g/l
2.7
2.4
0.40
41
331
(3052851) Hemolysis interference index of Serum or Plasma
10
72
1.40
0.37
1.7
3.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
41
1.47
0.36
1.2
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
136
1.26
0.34
1.3
1.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
91
1.33
0.34
1.8
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
38
432
0.86
0.33
2.4
2.6
e6/l
9.0
2.1
0.86
21
240
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
46
1.31
0.33
1.5
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
46
1.31
0.33
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
47
1.28
0.32
1.2
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
78
720
1.11
0.31
2.8
2.7
e6/l
0.7
0.8
0.12
62
533
(3018095) Leukocytes [#/volume] in Urine
98
916
1.10
0.30
3.7
3.3
e6/l
78.0
67.8
0.13
71
651
(3002582) Erythrocytes [#/volume] in Urine
85
789
1.10
0.30
3.3
2.9
e6/l
76.5
167.9
0.43
66
607
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
64
1.26
0.27
1.6
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
65
1.24
0.27
1.1
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
8
66
1.22
0.27
2.6
5.2
—
—
—
0
0
(4034850)
12
95
1.27
0.26
12.2
7.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
67
1.20
0.26
3.3
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
67
1.20
0.26
3.9
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
67
1.20
0.26
3.3
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
37
333
1.12
0.23
1.6
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
38
1.32
0.23
1.0
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
40
1.25
0.22
1.6
1.9
pg
31.4
33.5
—
5
40
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
42
1.19
0.21
2.6
1.6
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
11
0.00
0.21
0.0
1.1
—
104.4
—
0
11
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
11
0.00
0.21
0.0
1.2
—
258.0
—
0
6
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
132.6
—
0
11
(3044007) Cell count panel - Peritoneal fluid
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
10
0.00
0.21
0.0
1.0
—
105.8
—
0
10
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
18.3
—
0
10
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
12
0.00
0.21
0.0
1.3
—
1.1
—
0
6
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
11
134
0.81
0.21
1.8
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
21
183
1.16
0.20
1.0
1.3
iu/ml
24.3
148.5
—
7
83
(3005719) IgG [Mass/volume] in Serum or Plasma
18
208
0.86
0.20
3.2
3.2
g/l
9.6
10.7
0.53
18
195
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
49
1.23
0.20
2.3
1.7
—
—
—
0
0
(1002224) Polysomnography panel
15
127
1.19
0.20
1.1
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
50
1.20
0.20
1.0
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
24
270
0.88
0.20
2.4
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
51
1.18
0.19
1.3
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
18
157
1.15
0.17
2.7
3.4
pmol/l
4.2
4.4
0.41
18
144
(3016879) Cocaine [Presence] in Urine
7
62
1.13
0.17
3.6
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
63
1.11
0.17
1.1
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
68
1.18
0.16
3.4
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
131
1.15
0.14
2.5
3.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
64
673
0.94
0.14
6.1
7.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
30
325
0.92
0.14
1.4
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
48
455
1.06
0.11
1.5
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
19
173
1.10
0.10
1.7
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
16
177
0.90
0.10
1.9
1.8
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
44
1.14
0.10
2.6
2.9
mmol/l
3.7
4.0
—
5
44
(3035285) Chloride [Moles/volume] in Venous blood
5
44
1.14
0.10
2.6
2.9
mmol/l
101.8
105.0
—
5
44
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
44
1.14
0.10
5.4
3.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
46
1.09
0.09
2.6
2.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
10
114
0.87
0.09
3.0
2.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
14
126
1.12
0.09
1.4
2.0
mg/l
2.1
6.8
—
9
93
(3010421) pH of Blood
6
57
1.05
0.08
3.0
3.7
ph
7.5
7.4
—
6
43
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
5
60
0.83
0.08
4.0
1.8
g/l
0.0
0.0
—
5
53
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
5
62
0.80
0.08
4.0
1.8
g/l
0.0
0.0
—
5
54
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
64
0.78
0.08
1.0
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
64
0.78
0.08
1.2
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
79
813
0.96
0.08
1.7
1.7
mmol/l
1.3
1.4
0.44
71
683
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
65
0.77
0.08
2.0
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
65
1.08
0.08
1.3
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
71
0.84
0.07
1.7
1.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
6
70
0.85
0.07
1.0
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
6
73
0.82
0.07
3.0
2.6
mg/l
1.3
1.5
—
6
67
(1761482) Bacteria [#/volume] in Urine by Culture
8
78
1.03
0.07
2.0
4.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
7
82
0.85
0.07
3.6
2.0
%
82.3
90.5
—
7
77
(3009542) Hematocrit [Volume Fraction] of Blood
261
2630
0.97
0.07
13.5
13.8
%
39.3
40.3
0.68
170
1909
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
90
1.11
0.05
1.3
1.5
—
—
—
0
0
(3012544) pH of Venous blood
27
259
1.05
0.04
4.1
3.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
19
180
1.06
0.04
1.6
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
14
131
1.07
0.03
1.9
1.3
iu/l
25.6
32.6
0.37
14
110
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
14
131
1.07
0.03
4.1
2.3
%
1.2
1.2
0.04
14
131
(1761868) Lipid panel - Serum or Plasma
114
1154
0.98
0.03
3.1
2.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
64
628
1.02
0.03
2.1
2.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
60
591
1.02
0.02
1.6
1.4
nmol/l
19.1
21.0
0.45
50
495
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
32
328
0.97
0.02
2.1
5.2
ug/l
7.2
49.1
0.98
25
270
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
10
94
1.07
0.01
1.0
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
17
164
1.04
0.00
2.5
2.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
22
214
1.03
0.00
5.1
3.0
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
22
218
1.01
0.00
3.6
7.6
mmol/l
1.3
1.4
0.17
22
210
(3000991) Gas panel - Venous blood
22
218
1.01
0.00
3.3
8.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
45
452
0.99
0.00
1.9
2.4
e6/l
0.8
1.0
0.48
26
258
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
109
1.01
0.00
1.4
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
18
179
1.01
0.00
1.7
1.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
22
219
1.00
0.00
15.6
9.0
mmol/l
11.6
9.8
0.45
22
206
(3022217) INR in Platelet poor plasma by Coagulation assay
31
313
0.99
0.00
13.4
17.7
inr
1.4
1.2
—
5
44
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
105
0.95
0.00
1.6
2.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
84
837
1.00
0.00
2.2
2.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
70
703
0.99
0.00
4.8
4.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
26
264
0.98
0.00
4.2
3.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
50
505
0.99
0.00
2.4
2.9
ug/l
0.7
0.7
0.13
27
340
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
93
0.97
0.00
1.8
2.0
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
66
0.91
0.00
1.0
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
69
1.01
0.00
2.4
1.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
16.2
—
0
5
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
92
0.98
0.00
3.0
1.7
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
65
0.92
0.00
1.0
1.2
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
7
0.00
0.00
0.0
1.0
—
21.4
—
0
7
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
6.2
—
0
5
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
52
0.96
0.00
1.4
1.2
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
6
64
0.94
0.00
2.8
2.3
umol/l
27.5
30.8
—
6
55
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.8
—
6.9
—
0
8
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
73
0.96
0.00
2.4
1.7
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(4015189)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
8
0.00
0.00
0.0
1.0
—
3.3
—
0
8
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
4.0
—
0
5
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
6
68
0.88
0.00
4.0
1.8
g/l
0.0
0.0
—
6
60
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
7
0.00
0.00
0.0
3.0
—
72.3
—
0
7

Mortality – FinRegistry

↥

Association

Association between endpoint M13_CALCTENDINITIS and mortality.

Females

Parameter HR [95% CI] p-value
M13_CALCTENDINITIS 0.851 [0.67, 1.07] 0.175
Birth year 0.995 [0.99, 1.0] 0.238

During the follow-up period (1.1.1998 — 31.12.2019), 71 out of 1127 females with M13_CALCTENDINITIS died.

Males

Parameter HR [95% CI] p-value
M13_CALCTENDINITIS 0.862 [0.68, 1.09] 0.209
Birth year 0.988 [0.98, 1.0] 0.029

During the follow-up period (1.1.1998 — 31.12.2019), 73 out of 721 males with M13_CALCTENDINITIS died.

Mortality risk

Mortality risk for people of age

years, who have M13_CALCTENDINITIS.

N-year risk Females Males
1 0.077% 0.162%
5 0.494% 0.958%
10 1.316% 2.609%
15 2.429% 4.989%
20 4.252% 8.412%

Relationships between endpoints

↥

Index endpoint: M13_CALCTENDINITIS – Calcific tendinitis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data